ESTEVE Acquires Regis Technologies
July 31, 2025
ESTEVE (Esteve Química / ESTEVE CDMO) has acquired Regis Technologies, a Chicago-based contract development and manufacturing organization (CDMO) specializing in small-molecule APIs and separation products. The acquisition gives ESTEVE a physical U.S. presence, expands its early-stage development and cGMP API manufacturing capabilities, and adds ~70 employees to its US team.
- Buyers
- ESTEVE (Esteve CDMO / Esteve Química)
- Targets
- Regis Technologies, Inc.
- Industry
- Pharmaceuticals
- Location
- Illinois, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.